Accord BioPharma, Inc. et al. vs. Janssen Biotech, Inc. et al.

Explore the PTAB proceeding IPR2026-00259 filed by Accord BioPharma, Inc. et al. on 2026-03-20. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2026-00259

Filing Date

2026-03-20

Accorded Filing Date

2026-03-20

Institution Decision Date

2026-09-09

Last Modified Date

2026-10-07

Proceeding Type

IPR

Termination Date

—

Trial Status

Trial Instituted

Parties & Counsel

Petitioner

Accord BioPharma, Inc. et al.

Represented By

Green, Loraet al

Patent Owner / Respondent

Janssen Biotech, Inc. et al.

Represented By

Osman, Ingeet al

Tribunal & Venue

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Patent Information

1 Patent Involved

Respondent Application Number 17237650

Respondent Patent Number 12291566

External Links

Espacenet

Google Patents

Respondent Inventor Diane D. Harrison et al

Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Address and Attorney/Agent Information

30 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name Riverside Law LLP/J&J

Customer Number 171672

Address 175 Strafford Avenue, Suite 100, Wayne, PA, 19087, UNITED STATES

Attorney / Agent Information

Reg #	Name	Phone
32019	Paul Coletti	908-230-8324
41349	Brian Tomko	732-524-1239
41708	Eric Dichter	215-628-7966
44152	Paul Higgins	732-524-1728
44930	Thomas Mcwilliams	215-851-8100
46785	Eve Frank	732-524-2797
47785	Jeremy Mckown	732-524-6250
52066	Quang Nguyen	215-268-3885
52988	Melissa Miller	(651) 736-7586
56247	Rajiv Shah	2138925454
59049	Justin Allen	215-268-3881
59887	William Simmons	215-628-5512
65315	Dennis Haas Jr.	215-268-3888
67798	Ryan Artis	518-708-6044
69896	Xiaoxiao Xue	215-589-2066
70731	Pallab Singh	215-268-3888
71740	Qing Xia	858-320-3310
73405	Lin Chen	215-729-9231
73902	Jolie Lechner	215-628-5846
75974	Natalie Fonville	484-443-2889
76620	Philip Nigon	610-572-3639
77047	Joshua Javitz	202-776-5230
77278	Scott Allen	267-331-4461
78419	Steven Taylor	215-268-3888
80745	Russell Burkhardt	215-268-3888
81308	Kajan Ratnakumar	917-673-1871
81775	Ali Abdulhay	215-268-3888
81880	Joe-Yee Mak	610-872-5683
82930	Abigail Divito Evans	215-268-3893
83225	Sara Hanley	215-268-3888

Proceeding Documents

200

Patent Owner's Updated Mandatory Notices NOTICE

2026-10-07 FILING PARTY: PATENT OWNER

Download

Patent Owner's Updated Exhibit List NOTICE

2026-10-05 FILING PARTY: PATENT OWNER

Download

2126

Ex. 2126 566 Corrected K. Zhang Decl iso PHV Motion Exhibit

2026-10-05 FILING PARTY: PATENT OWNER

Download

Patent Owner's Notice of Intent NOTICE

2026-09-29 FILING PARTY: PATENT OWNER

Download

Patent Owner's Updated Exhibit List NOTICE

2026-09-29 FILING PARTY: PATENT OWNER

Download

Accord BioPharma, Inc. et al. vs. Janssen Biotech, Inc. et al.

Proceeding Overview

Parties & Counsel

Petitioner

Accord BioPharma, Inc. et al.

Represented By

Patent Owner / Respondent

Janssen Biotech, Inc. et al.

Represented By

Tribunal & Venue

Patent Information

Address and Attorney/Agent Information

Power of Attorney & Correspondence

Attorney / Agent Information

Proceeding Documents

Patent Owner's Updated Mandatory Notices NOTICE

Patent Owner's Updated Exhibit List NOTICE

Ex. 2126 566 Corrected K. Zhang Decl iso PHV Motion Exhibit

Patent Owner's Notice of Intent NOTICE

Patent Owner's Updated Exhibit List NOTICE

Ex. 2124 566 Declaration of R. Chin re PHV Exhibit

E-mail from the Board regarding provisionally recognized PTAB attorney Notices Exhibit

Patent Owner's Objections to Petitioner's Evidence OTHER

Patent Owner's Unopposed Motion for Pro Hac Vice Admission of Kevin N. Zhang MOTION

Patent Owner's Updated Exhibit List NOTICE

Ex. 2125 566 K. Zhang Decl iso PHV Motion Exhibit

Petitioner's Objections to Patent Owner's Evidence OTHER

Patent Owner's Notice of Intent NOTICE

Ex. 2124 566 Declaration of R. Chin re PHV Exhibit

SCHEDULING ORDER ORDER

Institution Decision: Grant DECISION

Director Discretionary Decision: Refer RESPONSE

IPR2026-00259 Petitioners Sur-reply Supporting Opp. to Discretionary Denial (566 patent) OTHER

Patent Owner's Surreply to Patent Owner's Preliminary Response OTHER

IPR2026-00259 Pre-Institution Reply to POPR (566 patent) OTHER

Patent Owner's Reply to Petitioners' Opposition to Patent Owner's Request for Discretionary Denial OTHER

Email Correspondence Exhibit

Email Correspondence Exhibit

Ex. 2064 - Wayback Machine Calendar re Clinicaltrials.gov Study NCT02186873 Exhibit

Ex. 2071 - Bai et al (2021) Exhibit

Ex. 2122 - Ruderman (2013) Exhibit

Ex. 2110 - van der Heijde et al (2009) Exhibit

Ex. 2074 - Elyan & Khan (2006) Exhibit

Ex. 2077 - Haibel et al, Six months open label trial of leflunomide... (2005) Exhibit

Ex. 2063 - NIH, ClinicalTrials.gov, Study of Ixekizumab (LY2439821) in TNF Inhibitor… (6.17.2020) Exhibit

Ex. 2067 - Kevzara Prescribing Information (Apr 2018) Exhibit

Ex. 2114 - van Vollenhoven (2009) Exhibit

Ex. 2116 - Ware, SF-36 Summary Measures Manual (1994) (EXCERPTS) Exhibit

Ex. 2105 - Taxonera et al (2017) Exhibit

Ex. 2113 - van Schie et al (2016) Exhibit

Ex. 2093 - Rugiene et al (2008) Exhibit

Ex. 2109 - van der Heijde et al (2008) Exhibit

Ex. 2078 - Haibel et al, Open label trial of anakinra... (2005) Exhibit

Ex. 2117 - Weinblatt (2013) Exhibit

Ex. 2099 - Sieper et al (2015) Exhibit

Ex. 2090 - Naganuma et al (2016) Exhibit

Ex. 2103 - Steiner et al (2017) Exhibit

Ex. 2123 - Fugger & Svejgaard (2000) Exhibit

Ex. 2088 - Murray & Rauz (2016) Exhibit

Ex. 2072 - Baraliakos et al (2007) Exhibit

Ex. 2107 - Upton & Mould (2014) Exhibit

Ex. 2102 - Song et al (2011) Exhibit

Ex. 2055 - Dr. Nigil Haroon CV Exhibit

Ex. 2111 - van der Heijde et al (2017) Exhibit

Ex. 2094 - Rutgeerts 2015 Exhibit

Ex. 2087 - Mould & Upton (2013) Exhibit

Ex. 2089 - Mustur et al (2009) Exhibit

Ex. 2052 - Simponi (golimumab) X0047 Withdrawal Assessment Report (Eur. Meds. Agency) (10.24.2013) Exhibit

Ex. 2059 - NIH, ClinicalTrials.gov, Study of Adalimumab in Patients... (9.9.2014) Exhibit

Ex. 2085 - Maksymowych & Brown (2009) Exhibit

Ex. 2079 - Haibel et al (2007) Exhibit

Ex. 2096 - Schett et al (2011) Exhibit

Ex. 2075 - Flamant et al (2017) Exhibit

Ex. 2091 - Pavelka et al (2015) Exhibit

Ex. 2062 - NIH, ClinicalTrials.gov, Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants… (11.19.2019) Exhibit

Ex. 2069 - Anderson et al (2001) Exhibit

Ex. 2083 - Lories & Baeten (2009) Exhibit

Ex. 2056 - J&J Press Release (10.20.2017) Exhibit

Ex. 2058 - NIH, ClinicalTrials.gov, An Efficacy and Safety Study of Golimumab… (6.14.2013) Exhibit

Ex. 2098 - Sieper et al (2014) Exhibit